# Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

> **NCT03392168** · PHASE1,PHASE2 · COMPLETED · sponsor: **Arcutis Biotherapeutics, Inc.** · enrollment: 91 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** ARQ-151 cream 0.5%
- **DRUG:** ARQ-151 cream 0.15%
- **DRUG:** ARQ-151 vehicle cream

## Key facts

- **NCT ID:** NCT03392168
- **Lead sponsor:** Arcutis Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-11
- **Primary completion:** 2018-05-02
- **Final completion:** 2018-05-02
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2022-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03392168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03392168, "Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03392168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*